Infectious Disease Control

9th International Conference on Typhoid, Invasive NTS Disease Held in Bali, Indonesia

BALI, Indonesia, May 1, 2015 /PRNewswire/ -- The Coalition against Typhoid (CaT) , in collaboration with Bio Farma , began the 9th International Conference on Typhoid and Invasive NTS Disease inBali, Indonesia, with more...

2015-05-01 20:17 1986

Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV)

PALO ALTO, Calif., April 27, 2015 /PRNewswire/ -- Eiger BioPharmaceuticals, Incorporated today announced the presentation of interim results of Phase 2 data of lonafarnib in patients with chronic hepatitis delta viral (HDV) infection. Data were presented from the LOWR HDV program, enrolled at Ank...

2015-04-27 22:04 2253

Closing The Gap For All Children

BEIJING, April 23, 2015 /PRNewswire/ -- On the eve of World Immunization Week ( April 24-30), UNICEF applauds the Government of China's achievement in protecting millions of children from vaccine-preventable diseases, and calls for sustained efforts to make sure every child is vaccinated to give t...

2015-04-23 18:20 2106

Sinovac Provides Updates on Pipeline Vaccines

BEIJING, March 17, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today provided updates on the Company's pipeline vaccines. EV71 vaccine. The Company submitted supplementary documentation to the China Food and Drug Administration...

2015-03-17 18:00 1614

Data Storytelling Heats up with Tableau Public's New Web Platform; Now Serving 90,000-plus authors

SEATTLE, March 12, 2015 /PRNewswire/ -- 2014 was a marquee year for Tableau Public, as more than 36,000 new authors joined and published more data stories than ever before. Tableau's free platform for creating, sharing and discovering data stories on the web now boasts more than 90,000 authors pu...

2015-03-12 08:22 2530

Mundipharma Demonstrates Efficacy of BETADINE(R) Formulations against Ebola Virus

SINGAPORE, Feb. 10, 2015 /PRNewswire/ -- Mundipharma has announced successful results from the testing ofBETADINE® formulations against the Ebola virus. The testing was conducted at Marburg University,Germany. BETADINE® products are used for skin disinfection and surgical skin preparations aroun...

2015-02-10 09:00 2020

European Hantavirus Diagnostics Market Tops US Market as a Result of Higher Disease Prevalence

MOUNTAIN VIEW, Calif., Jan. 27, 2015 /PRNewswire/ -- The European Hantavirus diagnostics market is growing at a compound annual growth rate (CAGR) of 5.8 percent, outperforming the U.S. market, which registered 3.7 percent. The European market is more robust primarily due to Hantavirus' high prev...

2015-01-27 20:45 1996

Nurses Call for End to Leprosy Discrimination

TOKYO, Jan. 27, 2015 /PRNewswire/ -- The Nippon Foundation and the International Council of Nurses jointly released Global Appeal 2015 in Tokyo on Jan. 27, calling for an end to the discrimination that people affected by leprosy continue to face in many parts of the world. It is the first time that ...

2015-01-27 16:00 1674

Frost & Sullivan Releases Drug Launch and Phase 3 Trial Watch List for Top Therapeutic Areas

MOUNTAIN VIEW, Calif., Jan. 13, 2015 /PRNewswire/ -- The therapeutics market is buzzing with activity, as several promising therapies are progressing toPhase 3 clinical trials and many more are awaiting commercial launches. As more complex specialty products are launched, the spending onpersonali...

2015-01-13 20:50 2060

EB Pharma Announces License Agreement for Investigational Drug, Tipifarnib from Janssen Pharmaceutica for Development in Hepatitis Delta (HDV)

PALO ALTO, California, Dec. 23, 2014 /PRNewswire/ -- EB Pharma, LLC., a subsidiary of Eiger BioPharmaceuticals, Inc., today announced that it has executed an agreement with Janssen Pharmaceutica NV, ("Janssen"), for an exclusive license, to tipifarnib in the field of virology and a related, clin...

2014-12-23 20:00 4498

Eiger Bio Receives Orphan Designation for Lonafarnib, a First In Class, Investigational Treatment for Hepatitis Delta Virus (HDV) Infection

PALO ALTO, California, Dec. 22, 2014 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. today announced that lonafarnib has been granted Orphan Designation by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA).  The U.S. Orphan Drug Act (ODA) provides for granting special...

2014-12-22 21:00 3045

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study

LOS ANGELES, Dec. 19, 2014 /PRNewswire/ -- Canopus BioPharma Inc. (OTC Pink: CBIA) today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition. Laboratories at the Texas Biomedical Research Institute in San Antonio Texas ...

2014-12-19 22:00 2269

Molecular Methods Rapidly Gain Ground in Infectious Disease Diagnostics, says Frost & Sullivan

MOUNTAIN VIEW, Calif., Dec. 11, 2014 /PRNewswire/ -- Unique disease outbreaks across the globe are escalating the demand for screening and spurring the infectious disease diagnostic market. Frost & Sullivan (www.Frost.com) Photo - http://pho...

2014-12-11 20:45 1732

Mundipharma Donates BETADINE Anti-viral Supplies to Direct Relief to Support the Fight Against Ebola in West Africa

SINGAPORE, Dec. 11, 2014 /PRNewswire/ -- Mundipharma today announces that it has partnered with Direct Relief, a leading aid organisation, to donate supplies of itsBETADINE® range of anti-virals to support the aid organisation's efforts to contain the current outbreak of Ebola inWest Africa. Dur...

2014-12-11 17:18 3594

Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative

LONDON and PITTSBURGH, Dec. 5, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) for its New Drug Applications (NDAs) for two dosages of abacavir/lamivudine ...

2014-12-05 00:53 3282

Institut Pasteur Appoints Isabelle Buckle, EVP, Research Applications and Industrial Partnerships and Pierre Legrain, EVP, Academic Development & Grant Office to Reinforce its Partnership Strategy Between Academia and Private Industry.

PARIS, Dec. 1, 2014 /PRNewswire/ -- Institut Pasteur, research institute of excellence in science, medicine and public health since 1887, and a network of 32 Institut Pasteur worldwide, announces the appointment of Dr.Isabelle Buckle, as Executive-Vice President Research Applications and Indust...

2014-12-01 15:01 2274

Paul G. Allen Extends Tackle Ebola Effort to Address Plight of Children Orphaned by Ebola

SEATTLE, Nov. 14, 2014 /PRNewswire/ -- Philanthropist Paul G. Allen today announced a multi-million dollar grant aimed at addressing one of the most tragic outcomes of the Ebola crisis inLiberia: the care of children orphaned by the virus. According to UNICEF, at least 3,700 children inGuinea, Li...

2014-11-14 04:49 2748

International SOS Unveils Free Ebola App for Mobile Devices

BEIJING, Nov. 13, 2014 /PRNewswire/ -- International SOS has released a new mobile app designed to help share its medical and travel information on Ebola. The free app is now available on iOS and Android devices. It will provide online, instant access to key sections fro...

2014-11-13 15:00 2537

Paul G. Allen Announces New Humanitarian Grants to Meet Real-Time Needs in Ebola-Stricken West Africa

SEATTLE, Nov. 6, 2014 /PRNewswire/ -- Philanthropist Paul G. Allen today announced new grants to provide immediate humanitarian relief to address basic human needs that are being threatened by the Ebola outbreak inWest Africa. Beginning today, these grants will enable aid organizations to provide...

2014-11-06 22:00 2805

Protection Against Norovirus by Human-Milk-Oligosaccharides

RHEINBREITBACH, Germany, Oct. 30, 2014 /PRNewswire/ -- Norovirus is the most common cause of viral epidemic gastroenteritis. About 18% of all gastroenteritis infections are caused by Norovirus affecting 267 million people worldwide every year. According to information of theRobert Koch-Institut...

2014-10-30 08:30 2260
1 ... 38394041424344 ... 46